B · Normal
"Science and Technology Innovation Board Daily" reported on the 16th that Hong Kong Exchange information showed that Citigroup's shareholding ratio in Hengrui Pharmaceuticals' H shares dropped from 6.00% to 5.29% on November 10.
Comments